YILI CHUANNING BIOTECHNOLOGY CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.62 CNY | -1.21% |
|
-1.21% | +26.43% |
| Aug. 26 | Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
| Jul. 11 | Yili Chuanning Biotechnology Gets Nod to Market Ursodeoxycholic Acid | MT |
EPS & Dividend: Yili Chuanning Biotechnology Co.,Ltd.
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | 0.35 | 0.42 | 0.51 |
| Rate of return | - | - | 3.3% | 3.95% | 4.8% |
| EPS 2 | 0.21 | 0.42 | 0.6533 | 0.78 | 0.9067 |
| Distribution rate | - | - | 53.6% | 53.8% | 56.2% |
| Reference price 2 | 8.95 | 8.40 | 10.62 | 10.62 | 10.62 |
| Nbr of stocks (in thousands) | 2,222,800 | 2,222,800 | 2,227,160 | - | - |
| Announcement Date | 3/12/23 | 4/10/24 | - | - | - |
1CNY in Million2CNY
Estimates
Past dividends: Yili Chuanning Biotechnology Co.,Ltd.
| 2024-05-21 | Annual 0.224559 CNY |
| 2023-05-28 | Annual 0.093 CNY |
Upcoming events: Yili Chuanning Biotechnology Co.,Ltd.
| 2024-10-21 | Q3 2024 Earnings Release (Projected) |
| 2025-04-07 | Q4 2024 Earnings Release (Projected) |
| 2025-04-28 | Q1 2025 Earnings Release (Projected) |
| 2025-08-25 | Q2 2025 Earnings Release (Projected) |
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| +0.57% | +0.66% | 58.43x | 40.26 | 18.1x | ||
| +1.26% | +1.66% | 39.78x | 27.88 | 13.85x | ||
| +2.80% | +3.07% | 21.39x | 5.693 | 4.63x | ||
| +3.22% | +3.33% | 37.65x | 40.89 | 7.14x | ||
| +2.60% | +2.73% | 15.77x | 6.109 | 5.01x | ||
| +3.70% | +3.79% | 15.97x | 5.832 | 3.78x | ||
| +1.97% | +2.07% | 28.23x | 5.807 | 5.08x | ||
| +3.27% | +3.39% | 21.48x | 5.252 | 4.95x | ||
| +2.76% | +2.98% | 51.27x | 35.64 | 6.9x | ||
| Average | +2.46% | +2.63% | 32.22x | 19.26 | 7.71x | |
| Weighted average by Cap. | +2.05% | +2.23% | 36.46x | 23.19 | 9.93x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews